CAS 35040-12-1
:4-({4-[(Z)-{4-[(4-aminophenyl)sulfonyl]phenyl}-NNO-azoxy]phenyl}sulfonyl)aniline
Azoxydapsone
CAS:Controlled ProductApplications Azoxydapsone is a primary urinary N-oxidation metabolite of Dapsone (D193250); an antibacterial used in the treatment of dermatitis herpetiformis.
References Israili, Z.H., et al.: J. Pharmacol. Exp. Ther., 187, 138 (1973); Cucinell, S.A., et al.: Am. J. Trop. Med. Hyg., 21, 322 (1972); Francis, J., et al.: Br. J. Pharmacol., 5, 565 (1950); Uetrecht, J., et al.: Clin. Dermatol., 7, 111 (1989); Reszka, K., et al.: Chem. Res. Toxicol., 22, 1137 (2009); Santos, J., et al.: Bioorg. Med. Chem., 17, 3795 (2009); Varma, M., et al.: J. Med. Chem., 52, 4844 (2009)Formula:C24H20N4O5S2Color and Shape:NeatMolecular weight:508.57Azoxydapsone
CAS:Azoxydapsone is a peptide that belongs to the group of activators. It activates the immune system by activating T-cells and B-cells, as well as stimulating the production of antibodies. Azoxydapsone has been shown to inhibit ion channels and protein interactions.
Formula:C24H20N4O5S2Purity:Min. 95%Molecular weight:508.6 g/mol


